Overexpression of miR146a-5p, as a novel prognostic marker, inhibits migration of human HT-29 colorectal cancer cells via down-regulating metastasis-related genes expression

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 344

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

CANCERMED04_042

تاریخ نمایه سازی: 17 مرداد 1398

Abstract:

Introduction & Aim: microRNAs are a group of post-transcription regulators whose expressions are altered in various cancers and contribute to cancer progression. According to studies, the expression of miR-146a-5p in some cancers, including colorectal cancer, is reduced. The purpose of this study was to restore of microRNA-146a-5p in HT-29 cell line and investigate the expression of metastasis-related genes in these cells. Methods. In this study, miR-146a-5p mimic was transfected into HT-29 cells via JetPEI transfection reagent. Transfection efficiency was evaluated by flow-cytometry. To evaluate the effects of miR-146a-5p replacement on the inhibition of cell migration, wound healing assay was performed. Finally, the expression levels of miR-146a-5p, vimentin, MMP9 and C-Myc were measured by the qRT-PCR method in HT-29 cells. Results. According to the obtained data, results of wound healing assays showed that miR-146a-5p mimic inhibited cell migration in HT-29 cell line compared with control groups. Finally, data of gene expression showed that miR-146a-5p mimic reduced vimentin, MMP9 and C-Myc gene expression compared to control cells. Conclusion. According to this study, the activation metastatic pathways were due to the down regulation of miR-146a-5p. According to this, miR-146a-5p can inhibit cells migration, in vitro, through down-regulating the expression of metastasis-related genes. Hence, miR-146a-5p can be a new diagnostic biomarker and new therapeutic target for colorectal cancer.

Authors

Saeed Noorolyai

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Ahad Mokhtarzadeh

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Elham Baghbani

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Amir Baghbanzadeh kojabad

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran